PRESS RELEASE OF THE CARDIOPROGRESS FOUNDATION
Main results of the XI International Forum
Novel PCSK9 Inhibitor Reduced LDL by 50%
Lerodalcibep, a novel, third-generation proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor, reduced low-density lipoprotein cholesterol (LDL-C) by more than 50% after 1 year in patients with or at a high risk for cardiovascular disease (CVD), new phase 3 results showed.
ACC/AHA Issue Updated Atrial Fibrillation Guideline
The American College of Cardiology (ACC), the American Heart Association (AHA), the American College of Chest Physicians (ACCP), and the Heart Rhythm Society (HRS) have issued an updated guideline for preventing and optimally managing atrial fibrillation (AF).
AHA Joins New Cardiovascular Certification Group ABCVM
The American Heart Association (AHA) has now formally voted to join several other cardiovascular societies to form a new professional certification board for cardiovascular medicine, to be known as the American Board of Cardiovascular Medicine (ABCVM).
Coronary artery calcium: from risk prediction to treatment allocation and clinical trials
Coronary artery calcium (CAC) is a direct measure of an individual’s coronary atherosclerotic burden.
FDA Okays First Extravascular ICD System
The US Food and Drug Administration has approved Medtronic's novel "extravascular" implantable cardioverter-defibrillator (Aurora EV-ICD) system, which uses a single lead implanted substernally to allow anti-tachycardia pacing and low-energy defibrillation while avoiding the vascular space for lead placement.
New Tool to Guide Transcatheter Aortic Valve Replacement
Researchers developed TJ-ICE–guided TAVR to facilitate implanting a heart valve at an optimal depth, guided by direct visualization of the membranous septum (MS) during the procedure.
Redefining CVD Risk: Cardiovascular-Kidney-Metabolic (CKM) Syndrome
Citing the strong overlap between heart disease, kidney disease, type 2 diabetes, and obesity, the American Heart Association (AHA) has for the first time formally defined what they are calling cardiovascular-kidney-metabolic (CKM) syndrome.
ACP Revises Standard on Cardiorespiratory Death Determination
The American College of Physicians (ACP) has issued a new position paper on determination of death that includes a clarification to the 1981 Uniform Determination of Death Act (UDDA), but otherwise reaffirms the current standards.
AHA Updates CPR Guidelines on Cardiac Arrest After Poisoning
The American Heart Association (AHA) has released a focused update on managing patients with cardiac arrest or life-threatening toxicity due to poisoning.
The update reflects treatment advances and new knowledge, including the use of venoarterial extracorporeal membrane oxygenation (VA-ECMO) for patients whose condition is refractory to poison antidotes and other therapies.
Nobel Prize Awarded to Covid Vaccine Pioneers
The physiology or medicine prize for Katalin Karikó and Drew Weissman recognized work that led to the development of vaccines that were administered to billions around the world.